Monitoring of endothelial permeability and plaque progression in a rabbit model of atherothrombosis using an albumin-binding MR contrast agent

Endothelial dysfunction, characterized by increased vascular permeability and impaired endothelial-dependent vasodilation, precedes and portends the development of atherosclerosis. MRI studies have shown that impaired focal endothelial dysfunction correlates with the extent of focal plaque burden in the coronary arteries. We have also reported that gadofosveset, an albumin-binding MR contrast agent, can be used to non-invasively assess endothelial permeability, plaque burden progression and regression in a murine model of accelerated atherosclerosis. To expand our previous findings we investigated the interplay between endothelial dysfunction, plaque progression and instability in a bigger animal (rabbit) model of accelerated disease.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.